Guru Ownership Trend
Guru Analysis for Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $244,593.28.
Top institutional holders include Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $300,796 net inflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Benitec Biopharma Inc. (BNTC)
Major holders include Cliff Asness ($300,796). According to the latest reported data, 1 tracked investment managers collectively hold approximately 22,481 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $300,796, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in BNTC during the most recent reporting period.
Yes, 1 managers opened new positions in BNTC, and 0 increased their existing holdings. The total reported buy value was $300,796.